Main content

The problem of parasites: who pays for neglected tropical diseases?

The pharmaceutical industry has ignored some diseases for decades. So what can be done?

Leishmaniasis may not be a household name in much of the rich world, but the parasitic disease is found in over 90 countries, and can lead to agonising disfigurements, and death. It’s classified as a neglected tropical disease, which means treatment is underfunded and under-researched. We hear from British adventurer and writer Pip Stewart, who contracted Leishmaniasis on an expedition through the jungle of Guyana. She received treatment in the UK, but it was a harrowing experience. Pip explains how her Guyanese friends have to resort to excruciating home remedies to try and stem the parasite. She’s written a book about her ordeal: Life Lessons from The Amazon. We also get the view from Ethiopia, where Dr Helina Fikre explains the difficulties in treating the same parasitic illness. Dr Laurent Fraisse from the Drugs for Neglected Diseases Initiative tells us about his organisation’s search for better treatments, while Dr Madhukar Pai calls for an overhaul of the way tropical diseases are funded. Image: The Leishmaniasis parasite under a magnification factor of 1000. Photo By BSIP/UIG Via Getty Images

Presenter: Vivienne Nunis
Producer: Sarah Treanor

Available now

18 minutes

Last on

Mon 13 Dec 2021 08:32GMT

Broadcast

  • Mon 13 Dec 2021 08:32GMT

Business Daily Podcast

Download every programme.

Podcast